(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

JIXING

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

JIXING

ST13

US500000097407895

Classe

5, 42

Pedido

97407895

Registro

7593041

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

32

Atualização mais recente

10/12/2024

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 42

Data de depósito

12/05/2022

Data de registro

10/12/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

10/12/2024

Última transação

10/12/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

3

Tipo de titular

03

Localização do titular

Shanghai, CN

Examinador

ABRAMS, JACQUELINE WILLETTE

Unidade examinadora

L10

Localização atual

FILE REPOSITORY (FRANCONIA)

Descrição da marca

The mark consists of the stylized word "JIXING" in green with the design of a broken heart to the left in color with the left side of the heart being orange and the right side being green with a helix in between the two sides.

Titulares e representantes

Titulares

Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.

Representantes

Erica Halstead WOMBLE BOND DICKINSON (US) LLP

Classificação técnica

Classes Nice

Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of asthma; cholesterol reducers; antihypertensives; anti-diabetic pharmaceuticals; anti-diabetic preparations; antiarrhythmics; cardiovascular pharmaceutical preparations; pharmaceutical preparation for eye or intraocular surgery; ophthalmic pharmaceutical products; ophthalmic preparations; medical preparations for use with eyes; medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; depuratives for the body; medicines for veterinary purposesveterinary diagnostic reagentsveterinary vaccinesAnti-infective products for veterinary useVeterinary preparationspain relief medication; Enzymes for veterinary purposes; biocides; disinfectant wipes; preparations to facilitate teething; diapers for pets; pharmaceutical candymedicated candies; medicines for human purposeshuman vaccine preparationsAntibiotics for human useanti-allergic and pain reduction medicines for treatment of illnesses for human purposes; pharmaceutical preparationspharmaceutical preparations for treatment of human illnessesheart disease and cancer; chemico-pharmaceutical preparationschemico-pharmaceutical preparations for treatment of human illnessesheart disease and cancer; ointments for pharmaceutical purposesantibioticsunburnanti-inflammatory ointments for pharmaceutical purposes; bronchodilating preparations; injectable pharmaceuticalsinjectable pharmaceuticals for treatment of anaphylactic reactions; tablets for pharmaceutical purposesmedicinal preparations for the mouth to be applied in the form of tablets and compressed tablets; tincture of iodine; herbal tinctures for medical purposes; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesterolemia

Classe 42

Scientific research and development; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; chemical research; biotechnology research; drug testing services; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness; Software as a service (SAAS) serviceshosting software for use by others for use in database managementuse as a spreadsheetword processing; pharmaceutical drug research services; pharmaceutical drug development services

Publicações

Histórico de despachos e eventos da marca no USPTO.

32 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/12/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/12/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/09/2024

PUBO

PUBLISHED FOR OPPOSITION

10/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

21/08/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/08/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/08/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/08/2024

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

22/01/2024

GNSL

LETTER OF SUSPENSION E-MAILED

22/01/2024

CNSL

SUSPENSION LETTER WRITTEN

22/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/01/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/01/2024

ALIE

ASSIGNED TO LIE

22/01/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

30/08/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

08/06/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

08/06/2023

CNSI

SUSPENSION INQUIRY WRITTEN

08/06/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

30/11/2022

GNSL

LETTER OF SUSPENSION E-MAILED

30/11/2022

CNSL

SUSPENSION LETTER WRITTEN

30/11/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

29/11/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/11/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

29/11/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

31/05/2022

GNRT

NON-FINAL ACTION E-MAILED

31/05/2022

CNRT

NON-FINAL ACTION WRITTEN

31/05/2022

DOCK

ASSIGNED TO EXAMINER

30/05/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

18/05/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

17/05/2022

NWAP

NEW APPLICATION ENTERED

16/05/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace JIXING ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.